What Trends Did You See at This Year’s JP Morgan Healthcare Conference?

Pharmaceutical Executive: What trends did you see at this year’s JP Morgan Healthcare Conference?
Clay Siegall: I’ve been going to this conference for 25 years. In some years, it’s very exciting. In other years, it’s down. I’ve seen it all. This year, there was good vibe in the hallways and the investors were upbeat.

The investors are looking for clinical data, which is always number one. It’s where the big value comes from. There was data from a fair number of companies, and clinical data leads to M&A activity, which is what investors expect in biotech.

The playbook for...